Switzerland· 37871060
Laxoberon Abführtropfen
A sodium picosulfate product containing natrii picosulfas monohydricus, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Sodium picosulfate is registered in 12 of 19 countries.
Countries holding a registration under ATC A06AB08 (sodium picosulfate), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 7 of them publish a price we can compare per daily dose
Sodium picosulfate · ATC A06AB08
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- natrii picosulfas monohydricus
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- A06AB08
- ATC class
- Sodium picosulfate
- Defined daily dose
- 5 mg, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768037871060730 mlCHF 16.05
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
516 interactions on record for sodium picosulfate.
Graded by severity as the source publishes them — 37 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sodium picosulfate · interactions on record
516 records
- 37 severe
- 475 moderate
- 4 minor
Most severe, free to view
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- ProcainamideC01BA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sodium picosulfate in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fae69e28-7bf2-4e55-82f2-caf9dfee8317 GET /v1/drugs/fae69e28-7bf2-4e55-82f2-caf9dfee8317?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "natrii picosulfas monohydricum 7.5 mg",
"valid_from": "1998-03-15",
"limitations": null,
"galenic_form": "Tropfen",
"therapeutic_area": null,
"sl_inclusion_date": "1998-03-15",
"self_retention_pct": 10
}See everything about sodium picosulfate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.